3.4.21.B50	malfunction	compared with the wild-type strain NCD-2, the degQ-null mutant has decreased extracellular protease and cellulase activities as well as antifungal ability against the growth of Babillus cinerea in vitro. The lipopeptides from the degQ-null mutant also have significantly decreased antifungal activity against Botrytis cinerea in vitro and in vivo. degQ-null mutant have a flatter colony phenotype and significantly decreased biofilm formation ability relative to the wild-type strain. The degQ-null mutant shows decreased fengycin production	-, 754649	
3.4.21.B50	malfunction	in domesticated Bacillus subtilis a promoter mutation decreases the rate of degQ transcription. The resulting low level of DegQ decreases DegU phosphorylation, relieving repression at the srfA promoter. As a result more ComS is synthesized and the degradation of ComK by MecA/ClpCP is decreased	753678	
3.4.21.B50	malfunction	the absence of DegQ does not affect outer membrane protein biogenesis in Neisseria meningitides	-, 717730	
3.4.21.B50	physiological function	DegQ does not act as a functional homolog of DegP and plays no role in outer membrane protein biogenesis in Neisseria meningitides	-, 717730	
3.4.21.B50	physiological function	DegQ may be an important regulatorof fengycin production and biofilm formation in Bacillus subtilis NCD-2	-, 754649	
3.4.21.B50	physiological function	E-cadherin cleavage is an important step in bacterial pathogenesis	-, 753173	
3.4.21.B50	physiological function	the regulation of the K-state in undomesticated strains of Bacillus subtilis requires the proper ratio of phosphorylated undunphosphorylated DegU, in accordance with the view that this protein acts as a rheostat for development	753678